PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8.16%
Some net income increase while AVGO is negative at -112.06%. John Neff would see a short-term edge over the struggling competitor.
-4.22%
Both reduce yoy D&A, with AVGO at -33.84%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
66.40%
Lower deferred tax growth vs. AVGO's 496.69%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-14.29%
Both cut yoy SBC, with AVGO at -6.39%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
1.48%
Slight usage while AVGO is negative at -40.74%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
269.39%
AR growth well above AVGO's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-73.53%
Both reduce yoy inventory, with AVGO at -154.76%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
555.56%
A yoy AP increase while AVGO is negative at -39.74%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-89.35%
Both reduce yoy usage, with AVGO at -37.93%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-2485.71%
Negative yoy while AVGO is 108.13%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-1.84%
Negative yoy CFO while AVGO is 40.39%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
20.86%
CapEx growth well above AVGO's 16.81%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-20.86%
Both yoy lines negative, with AVGO at -67.21%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-36.20%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
48.54%
We have some liquidation growth while AVGO is negative at -73.68%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
15.71%
Less 'other investing' outflow yoy vs. AVGO's 140.00%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-13.60%
Both yoy lines negative, with AVGO at -93.90%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-107.79%
Negative yoy issuance while AVGO is 105.26%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
5.00%
Buyback growth of 5.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.